Medical marijuana in Portugal may soon be accessible through pharmacies from April. The country legalized the use of medical cannabis in 2018 and established a regulated medical marijuana industry.
Portugal had earlier decriminalized the possession and use of illegal drugs such as marijuana in 2001, through Law 30/2000. The purpose of this was to limit drug problems. Costa Rica and Colombia also have similar policies.
The policy has established a certain number of grams that an individual would roughly consume in a period of 10 days. If an individual is caught in possession of an illegal drug whose quantity is more than the decriminalization amount stipulated for the drug, the individual will be brought before the Dissuasion of Drug Addiction panel, where their case will be examined. This will help determine individuals who need treatment.
This does not mean, however, that the distribution, growing and sale of these drugs is legal. These acts are still illegal under the law, with individuals convicted of trafficking facing anywhere from 1 to 12 years in prison, depending on the particulars of their case. Growing cannabis for personal use had been considered for decriminalization earlier in 2001 but had been withdrawn. This is why, even today, growing cannabis for personal use remains illegal in Portugal.
According to the June 2018 law that legalized marijuana medicines, a doctor is allowed to prescribe these medications, provided that all other therapies have either brought about unpleasant reactions or haven’t been successful in achieving the intended outcome.
Maria do Céu Machado, president of the Portuguese Medicines Agency Infarmed, stated that by the end of 2021, the agency would have identified regulations necessary to regulate cannabis medicines, including everything from marijuana cultivation to its distribution. Currently, the body oversees the regulation of drugs in the country.
Machado added that the organization was working to make sure that all the products manufactured in the future would be effective and of high quality. This, she said, would be done by creating laws for regulation and ensuring that finished products were sold in pharmacies.
Infarmed also granted market authorization to Tilray Inc. (NASDAQ: TLRY), which is a licensed global marijuana producer, to sell medical marijuana products in Portugal. This confirms that the company, which is the only company that has been granted authorization, produces medical products that meet the highest international and national standards. Tilray will be using its Portugal production facility to produce marijuana-based products that will be used in Portugal as well as be exported to the EU and other countries across the globe.
Tilray isn’t the only Canada-headquartered firm that has gained recognition in the medical/recreational cannabis space. Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) specializes in the plant-extraction space and now has ongoing cannabis extraction contracts with local and international partners.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.